LP
ANAB icon

LMR Partners’s AnaptysBio ANAB Stock Holding History

LMR Partners’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-140,722
Closed -$1.86M – 1354
2024
Q4 		$1.86M Buy
+140,722
New +$3.41M 0.02% 626
2020
Q2 		– Sell
-83,139
Closed -$1.18M – 591
2020
Q1 		$1.18M Sell
83,139
-50,000
-38% -$758K 0.05% 121
2019
Q4 		$2.16K Buy
+133,139
New +$3.15M ﹤0.01% 120

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LMR Partners's ANAB Position: Q1 2025 in Review

LMR Partners sold out of AnaptysBio (ANAB) in Q1 2025, closing a stake of 140,722 shares — an estimated $1.86M sold.

LMR Partners first reported a position in ANAB in Q4 2019 and held it in 3 quarters. The position peaked at $1.86M in Q4 2024. 153 funds tracked by Wall St. Rank hold ANAB as of Q1 2025.

  • LMR Partners reported no remaining AnaptysBio position as of Q1 2025 after selling out during the quarter.
  • LMR Partners sold 140,722 AnaptysBio shares in Q1 2025, an estimated $1.86M.
  • LMR Partners first reported a position in AnaptysBio in Q4 2019 and held it in 3 quarters.
  • LMR Partners's AnaptysBio position peaked at $1.86M in Q4 2024.
  • 153 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2025.

Based on LMR Partners's 13F filing for Q1 2025, filed 15 May 2025.